PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:09 AM ET

Sponsor Check › Person

PH
No photo found yet (own website and image search run after this page is viewed)

Peter Barton Hutt

Named as an officer, director or promoter on SEC Form D filings · ME, MA, CO · Sep 15, 2009 → Jul 11, 2017

15deals (issuers)
$1.4Breported sold
348investors
60Form D filings
2009–2017years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:19 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Peter Barton Hutt is listed as a director on 60 SEC Form D filings by 15 issuers between Jun 2009 and Apr 2025. Largest by amount reported sold: Moderna Therapeutics, Inc. (Cambridge, MA — biotechnology — 2016; $451.4M reported sold to 72 investors), Moderna LLC (Cambridge, MA — pharmaceuticals — 2013–2015; $446.1M reported sold to 43 investors), Cartesian Therapeutics, Inc. (Gaithersburg, MD — biotechnology — 2010–2017; $130M reported sold to 26 investors), Rubius Therapeutics, Inc. (Cambridge, MA — biotechnology — 2017; $115M reported sold to 27 investors), Seres Health, Inc. (Cambridge, MA — pharmaceuticals — 2014–2015; $65M reported sold to 20 investors) and 10 more (all listed below).

What this means That is a lot of deals — 15 separate companies raised money with this person listed as director, over about 16 years. Across those companies the filings report $1.4B sold in total.

Listed alongside Robert Langer (42 shared filings), Alan Crane (18 shared filings), Noubar Afeyan (18 shared filings), Omid Farokhzad (18 shared filings), Amir Nashat (16 shared filings) and 116 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Peter. Each name links to their own page.

The issuers belong to 2 sponsor groups: Moderna (2 issuers, $897.4M reported sold, 2013–2016) and Proterris (2 issuers, $5.46M reported sold, 2019–2022).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared the newest 50 of 60 public filings for Peter Barton Hutt and found 10 differences, 1 worth asking the sponsor about: 10 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Peter Barton Hutt has not run yet — it is joining a line of 8,337 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Peter Barton Hutt..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

10 differences found between the filings for Peter Barton Hutt — 1 worth asking about (compared the newest 50 of 60 filings on Oct 24, 2026; older filings not covered)

Worth asking · Mar 1, 2013 – Apr 29, 2025

10 Form Ds were filed more than 15 days after the first sale

Form D filed 140 days after the first sale — CEREHEALTH CORP · Form D filed 19 days after the first sale — Florey Biosciences, Inc. · Form D filed 17 days after the first sale — CEREHEALTH CORP · Form D filed 23 days after the first sale — Proterris Inc. · Form D filed 27 days after the first sale — SEVENTH SENSE BIOSYSTEMS, INC. · and 5 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Apr 29, 2020 ↗CEREHEALTH CORP — PartnerFacts page ↗Form D · Apr 29, 2025 ↗Florey Biosciences, Inc. — PartnerFacts page ↗
Sources
Note · May 10, 2011 – Feb 24, 2017

6 offerings changed their target amount between filings

Offering amount changed between filings — Axcella Health Inc. · Offering amount changed between filings — Axcella Health Inc. · Offering amount lowered between filings — SEVENTH SENSE BIOSYSTEMS, INC. · Offering amount changed between filings — Axcella Health Inc. · Offering amount changed between filings — Moderna LLC · and 1 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Feb 24, 2016 ↗Form D/A (later) · Feb 24, 2017 ↗Axcella Health Inc. — PartnerFacts page ↗Form D/A (earlier) · May 28, 2015 ↗
Sources
Note · Nov 7, 2011 – Apr 29, 2025

23 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Florey Biosciences, Inc. (latest filing Apr 29, 2025) · No amendment in the last 12 months on an offering that may still be open — CEREHEALTH CORP (latest filing Aug 10, 2023) · No amendment in the last 12 months on an offering that may still be open — Proterris Inc. (latest filing Aug 23, 2019) · No amendment in the last 12 months on an offering that may still be open — SEVENTH SENSE BIOSYSTEMS, INC. (latest filing Aug 22, 2018) · No amendment in the last 12 months on an offering that may still be open — SEVENTH SENSE BIOSYSTEMS, INC. (latest filing Feb 21, 2018) · and 18 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Apr 29, 2025 ↗Florey Biosciences, Inc. — PartnerFacts page ↗Form D/A · Aug 10, 2023 ↗CEREHEALTH CORP — PartnerFacts page ↗
Sources
Note · May 10, 2011 – Nov 17, 2011

Peter Barton Hutt is written 2 different ways on the filings

listed as "Peter Hutt" on 22 filings (from May 10, 2011), and "Peter Barton Hutt" on 29 filings (from Nov 17, 2011).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · May 10, 2011 ↗Form D · Nov 17, 2011 ↗Peter Barton Hutt — PartnerFacts page ↗
Sources
Note · Aug 6, 2015 – Jun 2, 2023

Same name, different state: "Peter Barton Hutt" (CA) is a separate record

This page covers filings where the address state is ME or MA or CO. A separate record, "Peter Barton Hutt" with address state CA, is listed on 5 filings — most recently by CoLabs Int'l, Corp. (Jun 2, 2023). Both records have filings in the same period (Aug 6, 2015 to Jul 11, 2017).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Peter Barton Hutt (CA) — PartnerFacts page ↗Form D/A · Jun 2, 2023 ↗CoLabs Int'l, Corp. — PartnerFacts page ↗Peter Barton Hutt (ME,MA,CO) — this page ↗
Sources
Note · Oct 3, 2022

Same name, different state: "Peter Barton Hutt" (VA) is a separate record

This page covers filings where the address state is ME or MA or CO. A separate record, "Peter Barton Hutt" with address state VA, is listed on 1 filing — most recently by Atelerix Life Sciences Inc. (Oct 3, 2022). The two records do not overlap in time: this page runs Sep 15, 2009 to Jul 11, 2017; the other has one filing dated Oct 3, 2022.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Peter Barton Hutt (VA) — PartnerFacts page ↗Form D · Oct 3, 2022 ↗Atelerix Life Sciences Inc. — PartnerFacts page ↗Peter Barton Hutt (ME,MA,CO) — this page ↗
Sources
Note · Dec 19, 2012 – Aug 9, 2013

Same name, different state: "Peter Hutt" (TX) is a separate record

This page covers filings where the address state is ME or MA or CO. A separate record, "Peter Hutt" with address state TX, is listed on 2 filings — most recently by NanoMedical Systems Inc (Aug 9, 2013). Both records have filings in the same period (Dec 19, 2012 to Aug 9, 2013).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Peter Hutt (TX) — PartnerFacts page ↗Form D/A · Aug 9, 2013 ↗NanoMedical Systems Inc — PartnerFacts page ↗Peter Barton Hutt (ME,MA,CO) — this page ↗
Sources
Note · Jul 27, 2012

Same name, different state: "Peter Barton Hutt" (UT) is a separate record

This page covers filings where the address state is ME or MA or CO. A separate record, "Peter Barton Hutt" with address state UT, is listed on 1 filing — most recently by Q Holdings, Inc. (Jul 27, 2012). Both records have filings in the same period (Jul 27, 2012).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Peter Barton Hutt (UT) — PartnerFacts page ↗Form D · Jul 27, 2012 ↗Q Holdings, Inc. — PartnerFacts page ↗Peter Barton Hutt (ME,MA,CO) — this page ↗
Sources
Note · Nov 16, 2016 – Sep 20, 2017

Address moved from Cambridge, MA to Medford, MA — SEVENTH SENSE BIOSYSTEMS, INC.

The people listed on the Nov 16, 2016 filing give Cambridge, MA; on the Sep 20, 2017 filing they give Medford, MA. The address now on file (200 Boston Avenue, Suite 3700, Medford, MA) is a registered-agent or shared-office address used by 8 issuers.

What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.

Form D · Nov 16, 2016 ↗Form D · Sep 20, 2017 ↗SEVENTH SENSE BIOSYSTEMS, INC. — PartnerFacts page ↗
Sources
Note · May 10, 2011 – Apr 29, 2025

Peter Barton Hutt is listed with 2 different address states: MA, CO

MA on 47 filings (May 10, 2011 to Apr 29, 2025); CO on 4 filings (Apr 29, 2020 to Aug 10, 2023).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · May 10, 2011 ↗Form D · Apr 29, 2020 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. We compared the newest 50 of 60 filings (work cap); older filings are not covered here. As of Oct 24, 2026.

5. Money to insiders

3 of 50 offerings report sales commissions totalling $2,749,375; 2 report finder's fees totalling $1,137,864; 1 reports proceeds to related persons totalling $102,083. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Apr 29, 2025 D
Florey Biosciences, Inc.
File 021-544696
$0$0$0None listed on this filingEDGAR ↗
Aug 10, 2023 D/A
CEREHEALTH CORP
File 021-411732
$0$0$102,083None listed on this filingEDGAR ↗
Apr 29, 2020 D
CEREHEALTH CORP
File 021-365960
$0$0$0None listed on this filingEDGAR ↗
Aug 23, 2019 D
Proterris Inc.
File 021-347268
$0$0$0None listed on this filingEDGAR ↗
Aug 22, 2018 D
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-319773
$0$0$0None listed on this filingEDGAR ↗
Feb 21, 2018 D
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-306068
$0$0$0None listed on this filingEDGAR ↗
Sep 20, 2017 D
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-295080
$17,500$0$0OUISA CAPITAL LLC BrokerCheck CRD 102840 ↗EDGAR ↗
Jul 11, 2017 D
Cartesian Therapeutics, Inc.
File 021-290444
$2,640,000 (est.)$0$0Stifel, Nicolaus & Company Incorporated BrokerCheck CRD 793 ↗EDGAR ↗
Jun 22, 2017 D
Rubius Therapeutics, Inc.
File 021-289273
$0$0$0None listed on this filingEDGAR ↗
Feb 24, 2017 D/A
Axcella Health Inc.
File 021-258026
$0$0$0None listed on this filingEDGAR ↗
Dec 14, 2016 D
Cartesian Therapeutics, Inc.
File 021-276281
$0$0$0None listed on this filingEDGAR ↗
Nov 16, 2016 D
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-274591
$0$0$0None listed on this filingEDGAR ↗
Aug 24, 2016 D
Moderna Therapeutics, Inc.
File 021-269500
$0$0$0None listed on this filingEDGAR ↗
Feb 24, 2016 D/A
Axcella Health Inc.
File 021-234192
$0$0$0None listed on this filingEDGAR ↗
Dec 22, 2015 D
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-253617
$0$0$0None listed on this filingEDGAR ↗
Sep 10, 2015 D
Cartesian Therapeutics, Inc.
File 021-247362
$0$0$0None listed on this filingEDGAR ↗
Aug 6, 2015 D/A
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-222564
$0$0$0None listed on this filingEDGAR ↗
Apr 23, 2015 D
Cartesian Therapeutics, Inc.
File 021-238498
$0$0$0None listed on this filingEDGAR ↗
Jan 5, 2015 D
Seres Health, Inc.
File 021-231428
$0$0$0None listed on this filingEDGAR ↗
Jan 5, 2015 D
Moderna LLC
File 021-231445
$0$0$0None listed on this filingEDGAR ↗
Dec 2, 2014 D
Seres Health, Inc.
File 021-229277
$0$0$0None listed on this filingEDGAR ↗
Aug 28, 2014 D
Cartesian Therapeutics, Inc.
File 021-223752
$0$0$0None listed on this filingEDGAR ↗
Aug 6, 2014 D
Salarius Pharmaceuticals, Inc.
File 021-222417
$0$0$0None listed on this filingEDGAR ↗
Jul 15, 2014 D
Cartesian Therapeutics, Inc.
File 021-221143
$0$0$0None listed on this filingEDGAR ↗
Jun 18, 2014 D
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-219417
$0$0$0None listed on this filingEDGAR ↗
Jun 9, 2014 D
Seres Health, Inc.
File 021-218762
$0$0$0None listed on this filingEDGAR ↗
Apr 10, 2014 D
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-215310
$0$0$0None listed on this filingEDGAR ↗
Apr 9, 2014 D
Cartesian Therapeutics, Inc.
File 021-215195
$0$0$0None listed on this filingEDGAR ↗
Mar 12, 2014 D
Tarveda Therapeutics, Inc.
File 021-213366
$0$0$0None listed on this filingEDGAR ↗
Jan 23, 2014 D/A
Moderna LLC
File 021-206659
$0$0$0None listed on this filingEDGAR ↗
Dec 24, 2013 D/A
Tarveda Therapeutics, Inc.
File 021-188774
$0$0$0None listed on this filingEDGAR ↗
Nov 21, 2013 D
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-206725
$0$0$0None listed on this filingEDGAR ↗
Apr 1, 2013 D
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-194292
$0$0$0None listed on this filingEDGAR ↗
Mar 18, 2013 D
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-193494
$0$0$0None listed on this filingEDGAR ↗
Feb 25, 2013 D
LIVING PROOF INC
File 021-192312
$0$1,122,864$0Leerink Swann LLC BrokerCheck CRD 39011 ↗
via Daniel Dubin (CRD 3231063 ↗)
EDGAR ↗
Feb 8, 2013 D
BIND Biosciences, Inc
File 021-191591
$0$0$0None listed on this filingEDGAR ↗
Jun 19, 2012 D/A
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-159505
$0$0$0None listed on this filingEDGAR ↗
Jun 1, 2012 D
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-179118
$0$0$0None listed on this filingEDGAR ↗
Apr 10, 2012 D
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-176410
$0$0$0None listed on this filingEDGAR ↗
Nov 22, 2011 D
BIND Biosciences, Inc
File 021-169119
$0$0$0None listed on this filingEDGAR ↗
Nov 17, 2011 D
Cartesian Therapeutics, Inc.
File 021-168905
$0$0$0
None other than salaries and bonuses in the ordinary course of business.
None listed on this filingEDGAR ↗
Nov 17, 2011 D
Cartesian Therapeutics, Inc.
File 021-168906
$0$0$0
None other than salaries and bonuses in the ordinary course of business.
None listed on this filingEDGAR ↗
Oct 13, 2011 D
BIND Biosciences, Inc
File 021-167172
$0$0$0None listed on this filingEDGAR ↗
Sep 2, 2011 D
Tarveda Therapeutics, Inc.
File 021-165360
$0$0$0None listed on this filingEDGAR ↗
Oct 14, 2010 D
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-149086
$0$0$0None listed on this filingEDGAR ↗
Jun 29, 2010 D
BIND Biosciences, Inc
File 021-144139
$0$0$0
Not including salaries and bonuses paid to executive officers in the ordinary course of business.
None listed on this filingEDGAR ↗
Jun 4, 2010 D
SEVENTH SENSE BIOSYSTEMS, INC.
File 021-142974
$0$0$0None listed on this filingEDGAR ↗
Apr 6, 2010 D
Cartesian Therapeutics, Inc.
File 021-125893
$0$0$0
None other than salaries and bonuses in the ordinary course of business.
None listed on this filingEDGAR ↗
Sep 15, 2009 D
Pervasis Therapeutics Inc
File 021-71452
$91,875 (est.)$15,000$0Musket Research Associates, Inc. BrokerCheck CRD 30599 ↗
via David B. Musket (CRD 1321808 ↗)
EDGAR ↗
Jun 18, 2009 D
LIVING PROOF INC
File 021-108750
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 15

Every issuer that named Peter Barton Hutt on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

FB
Biotechnology

Florey Biosciences, Inc.

Cambridge, MA · Apr 29, 2025
  • Apr 29, 2025 · D · $1,400,000 sold of $4,400,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $1.4M from 1 investor (32% of the $4.4M target) as of the latest filing. Peter is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CC
Other Health Care

CEREHEALTH CORP

Littleton, CO · Apr 29, 2020 → Aug 10, 2023 · 4 filings
  • Aug 10, 2023 · D/A · $2,881,532 sold of $5,250,000 · 47 investors · min. $25,000 · role: Director EDGAR ↗
  • Sep 7, 2022 · D/A · $2,248,532 sold of $5,250,000 · 33 investors · min. $25,000 · role: Director EDGAR ↗
  • Aug 30, 2021 · D · $525,000 sold of $5,250,000 · 10 investors · min. $25,000 · role: Director EDGAR ↗
  • Apr 29, 2020 · D · $2,250,000 sold of $2,250,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $5.19M from 47 investors (99% of the $5.25M target) as of the latest filing. Peter is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

P
Other Health Care · group: Proterris

Proterris Inc.

Boston, MA · Aug 23, 2019
  • Aug 23, 2019 · D · $1,999,999 sold of $25,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $2M from 1 investor (8% of the $25M target) as of the latest filing. Peter is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SS
Biotechnology

SEVENTH SENSE BIOSYSTEMS, INC.

Medford, MA · Jun 4, 2010 → Aug 22, 2018 · 18 filings
  • Aug 22, 2018 · D · $18,458,837 sold of $20,483,208 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 21, 2018 · D · $3,459,381 sold of $5,500,000 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 20, 2017 · D · $2,500,000 sold of $10,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 16, 2016 · D · $5,500,000 sold of $12,750,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 22, 2015 · D · $2,060,000 sold of $2,060,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 6, 2015 · D/A · $14,287,084 sold of $16,287,084 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 8, 2014 · D · $10,467,084 sold of $16,467,084 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 18, 2014 · D · $450,000 sold of $450,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 10, 2014 · D · $930,000 sold of $930,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 21, 2013 · D · $360,000 sold of Indefinite · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 1, 2013 · D · $157,500 sold of $157,500 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 18, 2013 · D · $1,800,000 sold of $1,800,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 19, 2012 · D/A · $12,182,963 sold of $12,182,963 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 1, 2012 · D · $200,000 sold of $200,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 10, 2012 · D · $750,000 sold of $750,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 10, 2011 · D · $6,682,964 sold of $12,182,962 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 14, 2010 · D · $2,100,000 sold of $2,100,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 4, 2010 · D · $1,500,000 sold of $1,500,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $18.5M from 18 investors (90% of the $20.5M target) as of the latest filing. Peter is listed as director on 18 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CT
Biotechnology

Cartesian Therapeutics, Inc.

Gaithersburg, MD · Apr 6, 2010 → Jul 11, 2017 · 10 filings
  • Jul 11, 2017 · D · $50,000,000 sold of $50,000,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 14, 2016 · D · $4,999,984 sold of $4,999,984 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 10, 2015 · D · $37,400,000 sold of $40,637,943 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 23, 2015 · D · $5,942,306 sold of $7,500,000 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 28, 2014 · D · $4,450,000 sold of $4,450,000 · 11 investors · min. $100,000 · role: Director EDGAR ↗
  • Jul 15, 2014 · D · $6,000,000 sold of $6,000,000 · 2 investors · min. $3,000,000 · role: Director EDGAR ↗
  • Apr 9, 2014 · D · $5,292,702 sold of $9,999,994 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 17, 2011 · D · $3,500,000 sold of $26,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 17, 2011 · D · $22,000,000 sold of $22,000,000 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 6, 2010 · D · $15,000,006 sold of $15,000,006 · 14 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $130M from 26 investors (100% of the $50M target) as of the latest filing. Peter is listed as director on 10 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

RT
Biotechnology

Rubius Therapeutics, Inc.

Cambridge, MA · Jun 22, 2017
  • Jun 22, 2017 · D · $115,000,060 sold of $120,000,064 · 16 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $115M from 27 investors (96% of the $120M target) as of the latest filing. Peter is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AH
Biotechnology

Axcella Health Inc.

Cambridge, MA · Feb 17, 2015 → Feb 24, 2017 · 6 filings
  • Feb 24, 2017 · D/A · $42,499,998 sold of Indefinite · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 24, 2016 · D · $42,499,998 sold of $42,499,998 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 24, 2016 · D/A · $44,317,970 sold of Indefinite · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 15, 2015 · D/A · $39,317,967 sold of Indefinite · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 28, 2015 · D/A · $39,317,967 sold of $39,317,967 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 17, 2015 · D · $28,299,993 sold of $28,299,993 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $44.3M from 12 investors as of the latest filing. Peter is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MT
Biotechnology · group: Moderna

Moderna Therapeutics, Inc.

Cambridge, MA · Aug 24, 2016
  • Aug 24, 2016 · D · $451,369,079 sold of $599,999,992 · 72 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $451.4M from 72 investors (75% of the $600M target) as of the latest filing. Peter is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

M
Pharmaceuticals · group: Moderna

Moderna LLC

Cambridge, MA · Nov 20, 2013 → Jan 5, 2015 · 3 filings
  • Jan 5, 2015 · D · $446,069,409 sold of $502,168,634 · 43 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 23, 2014 · D/A · $135,000,044 sold of $135,000,044 · 40 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 20, 2013 · D · $110,000,026 sold of $110,000,026 · 39 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $446.1M from 43 investors (89% of the $502.2M target) as of the latest filing. Peter is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SH
Pharmaceuticals

Seres Health, Inc.

Cambridge, MA · Jun 9, 2014 → Jan 5, 2015 · 3 filings
  • Jan 5, 2015 · D · $64,999,998 sold of $64,999,998 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 2, 2014 · D · $47,999,977 sold of $47,999,977 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 9, 2014 · D · $10,628,990 sold of $10,628,990 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $65M from 20 investors (100% of the $65M target) as of the latest filing. Peter is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SP
Biotechnology

Salarius Pharmaceuticals, Inc.

Houston, TX · Aug 6, 2014
  • Aug 6, 2014 · D · $16,224,982 sold of $22,000,000 · 20 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $16.2M from 20 investors (74% of the $22M target) as of the latest filing. Peter is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TT
Biotechnology

Tarveda Therapeutics, Inc.

Watertown, MA · Sep 2, 2011 → Mar 12, 2014 · 4 filings
  • Mar 12, 2014 · D · $999,999 sold of $999,999 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 24, 2013 · D/A · $21,001,164 sold of $21,001,168 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 20, 2012 · D · $16,001,168 sold of $21,001,168 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 2, 2011 · D · $2,800,000 sold of $2,800,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $38M from 13 investors (100% of the $1000K target) as of the latest filing. Peter is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

LP
Other

LIVING PROOF INC

Cambridge, MA · Jun 18, 2009 → Feb 25, 2013 · 2 filings
  • Feb 25, 2013 · D · $30,000,000 sold of $35,000,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 18, 2009 · D · $9,000,000 sold of $9,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $30M from 9 investors (86% of the $35M target) as of the latest filing. Peter is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

BB
Biotechnology

BIND Biosciences, Inc

Cambridge, MA · Jun 29, 2010 → Feb 8, 2013 · 4 filings
  • Feb 8, 2013 · D · $8,697,684 sold of $20,250,000 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 22, 2011 · D · $25,547,174 sold of $47,297,179 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 13, 2011 · D · $4,750,000 sold of $4,750,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 29, 2010 · D · $12,420,952 sold of $12,420,952 · 18 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $25.5M from 21 investors (100% of the $20.3M target) as of the latest filing. Peter is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

PT
Biotechnology

Pervasis Therapeutics Inc

Cambridge, MA · Sep 15, 2009
  • Sep 15, 2009 · D · $10,003,426 sold of $17,384,210 · 18 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $10M from 18 investors (58% of the $17.4M target) as of the latest filing. Peter is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (5)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Peter Barton Hutt — CA, 3 issuers, Aug 6, 2015 → Jun 2, 2023 · no shared issuer
  • Peter Barton-Hutt — CA, 1 issuer, Feb 9, 2021 → Sep 13, 2021 · no shared issuer
  • Peter Barton Hutt — UT, 1 issuer, Jul 27, 2012 → Jul 27, 2012 · no shared issuer
  • Peter Hutt — TX, 1 issuer, Dec 19, 2012 → Aug 9, 2013 · no shared issuer
  • Peter Barton Hutt — VA, 1 issuer, Oct 3, 2022 → Oct 3, 2022 · no shared issuer

People around Peter 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

RL
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Langer

Director · 42 shared filings (9 issuers) · also on 39 other issuers

Robert Langer is on 48 issuers in total — a repeat sponsor. Their page lists every one.

NA
No photo found yet (own website and image search run after this page is viewed)
Person

Noubar Afeyan

Director · 18 shared filings (6 issuers) · also on 8 other issuers

Noubar Afeyan is on 14 issuers in total — a repeat sponsor. Their page lists every one.

AC
No photo found yet (own website and image search run after this page is viewed)
Person

Alan Crane

Director · 18 shared filings (1 issuer) · also on 11 other issuers

Alan Crane is on 12 issuers in total — a repeat sponsor. Their page lists every one.

OF
No photo found yet (own website and image search run after this page is viewed)
Person

Omid Farokhzad

Director · 18 shared filings (3 issuers) · also on 1 other issuer

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

AN
No photo found yet (own website and image search run after this page is viewed)
Person

Amir Nashat

Executive Officer, Director · 16 shared filings (4 issuers) · also on 25 other issuers

Amir Nashat is on 29 issuers in total — a repeat sponsor. Their page lists every one.

HW
No photo found yet (own website and image search run after this page is viewed)
Person

HOWARD WEISMAN

Executive Officer, Director · 15 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

HB
No photo found yet (own website and image search run after this page is viewed)
Person

HOWARD BERNSTEIN

Executive Officer · 14 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Aymeric Sallin

Director · 14 shared filings (2 issuers)

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

HW
No photo found yet (own website and image search run after this page is viewed)
Person

HARRY WILCOX

Director, Executive Officer · 12 shared filings (1 issuer) · also on 6 other issuers

HARRY WILCOX is on 7 issuers in total — a repeat sponsor. Their page lists every one.

RA
No photo found yet (own website and image search run after this page is viewed)
Person

R. ROX ANDERSON

Director · 12 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

WC
No photo found yet (own website and image search run after this page is viewed)
Person

Werner Cautreels

Executive Officer, Director · 12 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

EK
No photo found yet (own website and image search run after this page is viewed)
Person

Edwin M. Kania, Jr.

Director · 10 shared filings (3 issuers) · also on 3 other issuers

Edwin M. Kania, Jr. is on 6 issuers in total — a repeat sponsor. Their page lists every one.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Connelly

Executive Officer, Director · 10 shared filings (2 issuers) · also on 3 other issuers

Robert Connelly is on 5 issuers in total — a repeat sponsor. Their page lists every one.

DB
No photo found yet (own website and image search run after this page is viewed)
Person

David Berry

Director · 10 shared filings (3 issuers) · also on 11 other issuers

David Berry is on 14 issuers in total — a repeat sponsor. Their page lists every one.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

John Mendlein

Director · 10 shared filings (3 issuers)

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Carl L. Gordon

Director · 9 shared filings (1 issuer) · also on 61 other issuers

Carl L. Gordon is on 62 issuers in total — a repeat sponsor. Their page lists every one.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

David Siewers

Executive Officer · 9 shared filings (1 issuer)

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

GS
No photo found yet (own website and image search run after this page is viewed)
Person

George Siber

Director · 8 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

YU
No photo found yet (own website and image search run after this page is viewed)
Person

Yuriy Udaltsov

Director · 8 shared filings (2 issuers)

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

DA
No photo found yet (own website and image search run after this page is viewed)
Person

David Abraham

Executive Officer · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

SH
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Hoge

Director, Executive Officer · 7 shared filings (2 issuers)

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

Doug Cole

Director · 6 shared filings (1 issuer) · also on 4 other issuers

Doug Cole is on 5 issuers in total — a repeat sponsor. Their page lists every one.

CC
No photo found yet (own website and image search run after this page is viewed)
Person

Charles Cooney

Director · 6 shared filings (1 issuer) · also on 7 other issuers

Charles Cooney is on 8 issuers in total — a repeat sponsor. Their page lists every one.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

Jeff Moore

Executive Officer · 6 shared filings (1 issuer)

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

GP
No photo found yet (own website and image search run after this page is viewed)
Person

Gary Pisano

Director · 6 shared filings (1 issuer)

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

NE
No photo found yet (own website and image search run after this page is viewed)
Person

Neil Exter

Director · 5 shared filings (1 issuer) · also on 6 other issuers

Neil Exter is on 7 issuers in total — a repeat sponsor. Their page lists every one.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

DON CHICKERING

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

LK
No photo found yet (own website and image search run after this page is viewed)
Person

Lorence Kim

Director, Executive Officer · 4 shared filings (3 issuers) · also on 4 other issuers

Lorence Kim is on 7 issuers in total — a repeat sponsor. Their page lists every one.

SM
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Minick

Executive Officer, Director · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

James Barrett

Director · 4 shared filings (1 issuer) · also on 6 other issuers

James Barrett is on 7 issuers in total — a repeat sponsor. Their page lists every one.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Stephane Bancel

Executive Officer, Director · 4 shared filings (2 issuers) · also on 3 other issuers

Stephane Bancel is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JA
No photo found yet (own website and image search run after this page is viewed)
Person

John Q. Adams, Sr.

Director · 4 shared filings (1 issuer)

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

TF
No photo found yet (own website and image search run after this page is viewed)
Person

T. Richard Fort

Director · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

LB
No photo found yet (own website and image search run after this page is viewed)
Person

Lee Babiss

Director · 4 shared filings (2 issuers)

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

LJ
No photo found yet (own website and image search run after this page is viewed)
Person

Lloyd Johnston

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

PK
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Keller

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

TK
No photo found yet (own website and image search run after this page is viewed)
Person

Takashi Kei Kishimoto

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

DH
No photo found yet (own website and image search run after this page is viewed)
Person

DONALD HARDISON

Director · 4 shared filings (1 issuer)

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

TR
No photo found yet (own website and image search run after this page is viewed)
Person

TIMOTHY RICHARDS

Executive Officer · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

ML
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Richard Lindsay

Director · 4 shared filings (1 issuer)

Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.

The team behind the deals

M
Sponsor group

Moderna

2 issuers · 4 filings · $897.4M reported sold · 2013–2016

One team, 2 deal companies. Peter Barton Hutt is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Peter Barton Hutt.

P
Sponsor group

Proterris

2 issuers · 3 filings · $5.46M reported sold · 2019–2022

One team, 2 deal companies. Peter Barton Hutt is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Peter Barton Hutt.

Same business address

42 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 15 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Peter Barton Hutt by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 15 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Peter Barton Hutt is listed on: none on file. No website or social profile named in Moderna Therapeutics, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #284,168 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Cambridge, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Maine state courts — find the court ↗Massachusetts MassCourts ↗Colorado state courts — find the court ↗Maryland Judiciary case search ↗Texas re:SearchTX court records ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Maine Secretary of State business search ↗Massachusetts Secretary of State business search ↗Colorado Secretary of State business search ↗Maryland Secretary of State business search ↗Texas Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Peter Barton Hutt appears on a new Form D, or when a court case or SEC action is matched to them. See plans →